Neuroimaging Biomarker for Seizures

Providence VA Medical Center224 enrolled

Overview

This multi-site study will examine patients with epilepsy (ES) following head injury \[i.e., posttraumatic epilepsy (PTE)\] and posttraumatic psychogenic Non-epileptic seizures (PNES) and will compare them to patients with traumatic brain injury (TBI) who do not have seizures using functional neuroimaging.

Numerous Veterans and civilians have seizures, which can be epileptic or nonepileptic in nature. Epileptic seizures are caused by abnormal brain cell firing. Nonepileptic seizures appear similar to epileptic seizures, but are associated with traumatic experiences and underlying psychological stressors. Both types of seizure are common and disabling, and many patients with seizures do not have adequate control resulting in loss of quality of life. In this proposed 3-site study ( Providence, RI and Birmingham, AL), which are epilepsy centers with expertise both in epilepsy and psychogenic nonepileptic seizures (PNES), we will enroll 88 patients with video-EEG confirmed PNES and 88 with confirmed post-traumatic epilepsy (PTE) and will obtain functional neuroimaging before and after they receive a behavioral treatment - Cognitive Behavioral Therapy for Seizures. The functional neuroimaging studies in these patients will be compared to patients with traumatic brain injury without seizures to test the hypothesis that the faulty processing of emotions and stress in patients with PNES/PTE and abnormal brain connectivity have unique signals in patients with seizures compared to Veterans without seizures and that the neuroimaging signatures can be modified using behavioral intervention. Impact: This grant application for the first study investigating mechanisms of PNES and PTE will provide increased understanding of neural circuitry in PTE and PNES, which can inform PTE and PNES treatments and could change clinical neurologic and psychiatric practice for PTE and PNES. Participants will be recruited at the Providence VA Medical Center, Rhode Island Hospital, and University of Alabama, Birmingham (UAB).

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Inclusion criteria for PNES, ES and TBI (w/o PNES or ES) participants * Individuals with history of documented TBI (any severity). * Males and Females ages 18-60 years . * Women of child bearing potential, if currently using appropriate contraception. Inclusion criteria of PNES and ES participants. * Diagnosed by video/EEG with lone PNES or by EEG with lone ES. * Patients must have at least 1 PNES or 1 ES during the year prior to enrollment. Exclusion Criteria: * Exclusion Criteria of PNES, ES and TBI (w/o PNES or ES) participants * Current or past year self-injurious behavior. * Current suicidal intent (BDI suicide question 9 score of \>1). * Current or past year psychosis. * Pending litigation or current application for long term disability. * Active substance or alcohol use disorder (dependence), per discretion of the investigators. * Serious illness requiring systemic treatment or hospitalization; the participant either completes therapy or is clinically stable on therapy, for at least 30 days prior to study entry. * Inability to fill out the self-report surveys. * Women who are or/are attempting to become pregnant during the study. * Ineligible or unwilling to complete MRI imaging. * Inability to document TBI. Exclusion Criteria for PNES and ES participants * Inability or unwillingness to participate in CBT and assigned homework. * Currently enrolled in cognitive therapy aimed at PNES (Current CBT or other psychotherapy may be administered). * Concurrent mixed ES/PNES or equivocal video/EEG findings in discerning between ES and PNES will not be enrolled.

Outcomes

Primary Outcomes

Number of Epileptic Seizures

epileptic seizure frequency (ES), collected prospectively, using a daily seizure calendar

Time frame: Baseline, Weeks 1,2,3,4,5,6,7,8,9,10,11,12, 8 months post baseline, 12 months post baseline

Number of Nonepileptic Seizures (NES)

psychogenic nonepileptic seizure (NES) frequency, collected prospectively, using a daily seizure calendar

Time frame: Baseline, Weeks 1,2,3,4,5,6,7,8,9,10,11,12, 8 months post baseline, 12 months post baseline

Structural and Functional Neuroimaging

Brain MRI scans

Time frame: Baseline and week 13

Secondary Outcomes

Beck Depression Inventory-II (BDI-II)

The BDI-II assesses depression severity from "0" (no Depression-related symptom) to "3" (severe) on each question. The highest possible score is "51", relating to the worst outcome.

Time frame: Baseline, Weeks 1,2,3,4,5,6,7,8,9,10,11,12, 8 months post baseline, 12 months post baseline

Beck Anxiety Inventory (BAI)

The BDI-II assesses anxiety severity from "0" (no Anxiety-related symptom) to "3" (severe) on each question.

Time frame: Baseline, Weeks 6 and 10, 8 months post baseline, 12 months post baseline

Quality of Life in Epilepsy-31 (QOLIE-31)

his is a 31-item self-report scale used in the seizure population to evaluate Quality of Life. The lowest possible score is 0 and the highest possible score is 100, reflecting a better quality of life.

Time frame: Baseline, Weeks 6 and 10

Neuroimaging Biomarker for Seizures

Overview

Conditions

Interventions

Eligibility

Locations (3)

Outcomes

Primary Outcomes

Secondary Outcomes